- Renin-inhibitor Aliskiren in the therapy of cardiovascular diseases2008 | First Faculty of Medicine
- Direct renin inhibitor aliskiren in the treatment of cardiovascular and renal disease2010 | First Faculty of Medicine
- Aliskiren, renin inhibitor, new hope for patients in diabetic nephropathy2009 | First Faculty of Medicine
- Direct renin inhibitors: new class of antihypertensive agents2008 | First Faculty of Medicine
- Renin, prorenin, and the direct renin inhibitor aliskiren2010 | First Faculty of Medicine
- Current options in the treatment of the progrssion of diabetic nephropathy2010 | First Faculty of Medicine
- Cardiorenal end points in a trial of Aliskiren for type 2 diabetes2012 | First Faculty of Medicine
- The renin inhibitor -aliskiren lowers proteinuria in patients type 2 diabetes and nephropathy treated by maximum of losartan. Commentary on: NEJM 358,2008,s. 2433-24462008 | First Faculty of Medicine
- Fixed combination aliskiren/hydrochlorothiazide2011 | First Faculty of Medicine
- Aliskirene2009 | First Faculty of Medicine
- The position of aliskiren on cardiovascular disease in the light of the ALTITUDE study.2012 | First Faculty of Medicine
- Zarethan in the treatment of hypertension2008 | Third Faculty of Medicine
- Commentary on AVOID study2009 | First Faculty of Medicine
- Arterial hypertension - current clinical trends 92011 | First Faculty of Medicine
- Antagonists of the renin-angiotensin-aldosterone system2011 | First Faculty of Medicine
- Aliskiren/hydrochlorothiazide - fixed combination2010 | Third Faculty of Medicine
- Irbesartan in the treatment of arterial hypertension, diabetes and nephropathy2011 | First Faculty of Medicine, Third Faculty of Medicine
- News in the treatment of diabetic nephropathy2014 | First Faculty of Medicine
- New advances in treating diabetic nephropathy2011 | First Faculty of Medicine
- Despite Similar Reduction of Blood Pressure and Renal ANG II and ET-1 Levels Aliskiren but not Losartan Normalizes Albuminuria in Hypertensive Ren-2 Rats2010 | Second Faculty of Medicine
- Moderate additive effects of endothelin receptor A blockade in Ren-2 transgenic rats subjected to various types of RAS blockade2016 | Central Library of Charles University
- Role of angiotensin II in chronic blood pressure control of heterozygous Ren-2 transgenic rats: Peripheral vasoconstriction versus central sympathoexcitation2019 | Central Library of Charles University
- Cardiorenal end points in a trial of aliskiren for type 2 diabetes2012 | Second Faculty of Medicine
- Persistent antihypertensive effect of aliskiren is accompanied by reduced proteinuria and normalization of glomerular area in Ren-2 transgenic rats2010 | Third Faculty of Medicine, Second Faculty of Medicine